Your browser doesn't support javascript.
loading
LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics.
Adashek, Jacob J; Kato, Shumei; Nishizaki, Daisuke; Miyashita, Hirotaka; De, Pradip; Lee, Suzanna; Pabla, Sarabjot; Nesline, Mary; Conroy, Jeffrey M; DePietro, Paul; Lippman, Scott; Kurzrock, Razelle.
Afiliação
  • Adashek JJ; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Kato S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California, USA.
  • Nishizaki D; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California, USA.
  • Miyashita H; Dartmouth Cancer Center, Hematology and Medical Oncology, Lebanon, New Hampshire, USA.
  • De P; Avera Cancer Institute, Sioux Falls, South Dakota, USA.
  • Lee S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California, USA.
  • Pabla S; OmniSeq Inc., Buffalo, New York, USA.
  • Nesline M; OmniSeq Inc., Buffalo, New York, USA.
  • Conroy JM; OmniSeq Inc., Buffalo, New York, USA.
  • DePietro P; OmniSeq Inc., Buffalo, New York, USA.
  • Lippman S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, California, USA.
  • Kurzrock R; WIN Consortium, San Diego, California, USA.
Cancer Med ; 12(12): 13155-13166, 2023 06.
Article em En | MEDLINE | ID: mdl-37132280

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nivolumabe / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nivolumabe / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos